Senior Reverse Engineer / CNO Developer (TS/SCI)

GliaCell Technologies; Laurel (NE); On-site; USD 200,000 - 280,000; Full time

Benefits offered by this job

Long-term job security

Competitive salaries & bonus

Work From Home Opportunities

401K Company Contribution

Job summary

GliaCell Technologies is seeking a Senior Reverse Engineer / CNO Developer for a full-time on-site role in Laurel, MD. You will design, develop, prototype, modify, and integrate mission-centric software for government contracts.

Responsibilities include augmenting toolsets, deriving requirements, building prototypes, and delivering end-to-end solutions while collaborating with analysts, operators, and other engineers. A TS/SCI with Polygraph clearance is required.

Qualifications

• Active or rein-statable TS/SCI with Polygraph clearance is required.
• U.S. citizenship is mandatory for all applicants.
• 12 years of professional experience with a BS or 4 extra years in lieu of a BS.
• Able to work independently and in a team with strong communication.

Responsibilities

• Augment existing toolsets to meet mission requirements.
• Derive, document, and analyze development requirements.
• Build prototypes to demonstrate understanding of mission needs.
• Deliver end-to-end toolsets within mission constraints.
• Provide technical consulting and perform peer code reviews.

Skills

Reverse engineering

C/C++/Python

Cross-functional collaboration

Education

Bachelor's degree in Science

12 years of professional experience

Tools

Git

Subversion

Jira

Confluence

Bamboo

Job description

GliaCell Technologies is seeking a Senior Reverse Engineer / CNO Developer for a full-time on-site role in Laurel, MD. You will design, develop, prototype, modify, and integrate mission-centric software for government contracts.

Responsibilities include augmenting toolsets, deriving requirements, building prototypes, and delivering end-to-end solutions while collaborating with analysts, operators, and other engineers. A TS/SCI with Polygraph clearance is required.